Antimicrobial Agents Practice Questions

Q: A woman presenting with symptoms of urinary tract infection was prescribed a drug that causes tendon rupture and arthropathy. What is the mechanism of action of the drug?

DNA gyrase inhibition. ***DNA gyrase inhibition*** - The description of a drug causing **tendon rupture** and **arthropathy** in the context of a urinary tract infection (UTI) suggests a **fluoroquinolone**. - Fluoroquinolones exert their bactericidal effect by inhibiting **bacterial DNA gyrase** (also known as topoisomerase II) and **topoisomerase IV**, thereby preventing DNA replication and repair. *Ribosomal inhibition* - This mechanism is characteristic of antibiotics like **aminoglycosides**, **tetracyclines**, and **macrolides**. - While some of these can treat UTIs, they are not typically associated with **tendon rupture** or **arthropathy** as major side effects. *Cell wall synthesis* - This is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillins, cephalosporins) and **vancomycin**. - These drugs are common for UTIs but do not cause **tendon rupture** or **arthropathy**. *Inhibition of folic acid synthesis* - This mechanism is used by **sulfonamides** and **trimethoprim**, often combined as trimethoprim-sulfamethoxazole. - While effective for UTIs, these drugs are not known to cause **tendon rupture** or **arthropathy**.

Q: Drug of choice for invasive aspergillosis is

Voriconazole. ***Voriconazole*** - **Voriconazole** is the **first-line drug of choice** for the treatment of **invasive aspergillosis** due to its superior efficacy and good CNS penetration compared to other antifungals. - It works by inhibiting the fungal enzyme **14-alpha-demethylase**, disrupting ergosterol synthesis in the fungal cell membrane. *Posaconazole* - **Posaconazole** is a broad-spectrum triazole antifungal, primarily used for **prophylaxis** of invasive fungal infections in high-risk patients. - While it has activity against *Aspergillus*, it is generally considered a **second-line agent** for treatment or for salvage therapy if voriconazole fails. *Liposomal AMB* - **Liposomal amphotericin B (AMB)** is an effective antifungal for invasive aspergillosis, particularly in patients who **cannot tolerate voriconazole** or have contraindications. - It is often considered a **second-line or alternative therapy** rather than the first-line drug of choice. *Caspofungin* - **Caspofungin** is an **echinocandin** antifungal that inhibits the synthesis of **beta-(1,3)-D-glucan**, a crucial component of the fungal cell wall. - While active against *Aspergillus*, it is typically used as **salvage therapy** or in combination with other antifungals for invasive aspergillosis, not as a monotherapy first-line drug.

Q: What is the primary site of action of amphotericin B?

Plasma membrane. ***Plasma membrane*** - Amphotericin B primarily acts at the **fungal cell membrane**, specifically by binding to **ergosterol**, a sterol essential for fungal membrane integrity. - This binding leads to the formation of **pores** or channels in the membrane, causing leakage of intracellular ions and macromolecules, thus disrupting cellular function and causing cell death. *Cell wall* - The **cell wall** is mainly composed of **chitin** and glucans, which provide structural rigidity to fungal cells. - Amphotericin B does not directly target the fungal cell wall; instead, its action is focused on the underlying **plasma membrane**. *Protein* - Amphotericin B is a **polyene antifungal** medication and is not primarily involved in targeting or inhibiting protein synthesis. - Inhibition of **protein synthesis** is a mechanism seen in certain antibacterial agents (e.g., tetracyclines, macrolides) but not in amphotericin B. *Ribosomes* - **Ribosomes** are responsible for protein synthesis and are not the primary target of amphotericin B. - While disrupting the cell membrane can indirectly affect various cellular processes, including protein synthesis, it is not a direct site of action for this drug.

Q: What is the drug of choice for treating Cyclosporiasis?

Trimethoprim-sulfamethoxazole combination. ***Trimethoprim-sulfamethoxazole combination*** - **Trimethoprim-sulfamethoxazole (TMP-SMX)** is the highly effective and **drug of choice** for treating **Cyclosporiasis**, particularly in both immunocompetent and immunocompromised individuals. - It is administered orally and works by inhibiting folic acid synthesis in the parasite. *Paromomycin* - **Paromomycin** is an aminoglycoside antibiotic primarily used for treating intestinal amebiasis and cryptosporidiosis, but it is **not effective** against Cyclosporiasis. - It exhibits poor systemic absorption and thus primarily acts within the gastrointestinal tract. *Metronidazole* - **Metronidazole** is commonly used to treat infections caused by anaerobic bacteria and certain parasites like *Giardia* and *Entamoeba histolytica*, but it is **ineffective** against *Cyclospora cayetanensis*. - Its mechanism of action involves disrupting DNA and protein synthesis in susceptible organisms. *Cyclosporin* - **Cyclosporin** is an immunosuppressant drug used to prevent organ transplant rejection and treat autoimmune diseases, and it has **no antiparasitic activity** against *Cyclospora*. - Its primary function is to inhibit T-lymphocyte activation.

Q: Burkholderia cepacia is resistant to which of the following antibiotics?

Cefotetan. ***Cefotetan*** - *Burkholderia cepacia* shows **consistent resistance** to second-generation cephalosporins and cephamycins like **cefotetan**. - This organism is intrinsically resistant to **aminoglycosides** (gentamicin, tobramycin) and **polymyxins** (colistin), and shows variable resistance to many beta-lactams. - Among the options provided, cefotetan represents the most consistently ineffective agent. *Ceftazidime* - **Ceftazidime** (third-generation cephalosporin) shows **variable susceptibility** with *B. cepacia*. - While resistance is common, it is **not uniform**, and ceftazidime is sometimes used in **combination therapy** for B. cepacia infections. - Not considered a classic example of intrinsic resistance. *Trimethoprim-sulfamethoxazole* - **TMP-SMX** is the **first-line treatment** for *Burkholderia cepacia* infections. - It demonstrates good activity and is the preferred antimicrobial agent for this organism. - Resistance can develop but is not intrinsic. *Temocillin* - **Temocillin** (carboxypenicillin) has demonstrated activity against *B. cepacia*. - Used particularly in Europe for treating infections caused by this organism. - Not an antibiotic to which *B. cepacia* shows consistent resistance.

Q: What is the drug of choice for treating isosporiasis?

Co-trimoxazole. ***Co-trimoxazole*** - **Co-trimoxazole** (trimethoprim-sulfamethoxazole) is the **drug of choice** for treating **isosporiasis** (*Cystoisospora belli*, formerly *Isospora belli*), particularly in both immunocompetent and immunocompromised individuals. - Its mechanism of action involves inhibiting **folic acid synthesis** in the parasite through sequential blockade of the folate pathway, leading to its death. - Standard dose: **TMP 160 mg/SMX 800 mg QID for 10 days** in immunocompetent patients; HIV patients may require longer therapy and secondary prophylaxis. *Penicillin G* - **Penicillin G** is an **antibiotic** primarily used to treat bacterial infections, such as those caused by Streptococcus and Staphylococcus species. - It has **no activity** against **Isospora belli**, which is a parasitic protozoan infection. *Benzathine penicillin* - **Benzathine penicillin** is a **long-acting form of penicillin** commonly used for syphilis and rheumatic fever prevention due to its prolonged release. - Like penicillin G, it is an antibacterial agent and is **ineffective against parasitic infections** like isosporiasis. *Albendazole* - **Albendazole** is an **antihelminthic drug** used to treat a variety of helminth infections, such as hookworm, roundworm, and tapeworm. - It is **not effective** against **Isospora belli**, which is a protozoan parasite, not a helminth.

Q: Mycoplasma is inherently resistant to which of the following antibiotic classes due to its lack of a peptidoglycan cell wall?

Ceftriaxone (a cephalosporin). ***Ceftriaxone (a cephalosporin)*** - Cephalosporins are **beta-lactam antibiotics** that inhibit **peptidoglycan cell wall synthesis** by binding to penicillin-binding proteins (PBPs) - *Mycoplasma* species **completely lack a peptidoglycan cell wall**, which is the primary target of all beta-lactam antibiotics - Therefore, cephalosporins (and all beta-lactams) are **inherently ineffective** against *Mycoplasma* infections - This is a classic example of **intrinsic resistance** due to absence of the drug target *Penicillins (e.g., Amoxicillin)* - While penicillins are also beta-lactam antibiotics that target cell wall synthesis, the question specifically asks about ceftriaxone - Penicillins are similarly ineffective against *Mycoplasma* for the same reason (lack of cell wall) - However, when given a specific drug example (ceftriaxone), it is the most precise answer *Aminoglycosides (e.g., Gentamicin)* - Aminoglycosides target the **30S ribosomal subunit** to inhibit **protein synthesis** - While they have **poor penetration** into *Mycoplasma* cells and limited clinical efficacy, the resistance is not due to lack of cell wall - The mechanism of reduced susceptibility is different from the intrinsic resistance seen with beta-lactams *Fluoroquinolones (e.g., Ciprofloxacin)* - Fluoroquinolones inhibit **DNA gyrase** and **topoisomerase IV**, enzymes essential for DNA replication - These antibiotics are **effective** against *Mycoplasma* species and are commonly used to treat *Mycoplasma* infections - They represent appropriate treatment options along with macrolides and tetracyclines

Q: Mechanism of action of Oseltamivir?

Neuraminidase inhibitor. ***Neuraminidase inhibitor*** - **Oseltamivir** prevents the release of new influenza virus particles from infected cells by inhibiting **neuraminidase**, an enzyme essential for viral replication. - This inhibition limits the spread of the virus to uninfected cells, thereby reducing the severity and duration of the **flu**. *Inhibitor of protein synthesis* - This mechanism is characteristic of certain **antibiotics** (e.g., tetracyclines, macrolides) or **antitumor agents**, not antiviral medications like oseltamivir. - Inhibiting protein synthesis would interfere with the host cell's vital functions and is not the primary target for influenza antivirals. *Inhibitor of thymidylate synthetase* - **Thymidylate synthetase inhibitors** (e.g., 5-fluorouracil) are primarily used in **cancer chemotherapy** to block DNA synthesis in rapidly dividing cells. - This mechanism is not relevant to the action of oseltamivir against influenza virus. *Pyrimidine analogs* - **Pyrimidine analogs** (e.g., zidovudine, fluorouracil) are drugs that mimic natural pyrimidine bases and interfere with nucleic acid synthesis. - While some antivirals act as nucleoside/nucleotide analogs, this is a broader category, and oseltamivir's specific action is not as a pyrimidine analog.

Q: Which antiretroviral drug also has anti-hepatitis activity?

Tenofovir. ***Tenofovir*** - **Tenofovir** is a nucleotide reverse transcriptase inhibitor (NtRTI) that is highly effective against both **HIV** and **Hepatitis B virus (HBV)**. - It is a **first-line agent** for HBV treatment with a **high barrier to resistance**, making it the preferred choice for dual therapy in HIV/HBV coinfection. - It is FDA-approved for both HIV and HBV treatment and is a key component in antiretroviral therapy (ART) regimens for coinfected patients. *Abacavir* - **Abacavir** is a nucleoside reverse transcriptase inhibitor (NRTI) used for HIV treatment. - It does not have significant activity against **Hepatitis B virus (HBV)** or other hepatitis viruses. *Emtricitabine* - **Emtricitabine** is a nucleoside reverse transcriptase inhibitor (NRTI) that has activity against both **HIV** and **HBV**. - While it is FDA-approved for HBV treatment, it has a **lower barrier to resistance** compared to tenofovir and is less preferred as monotherapy for HBV. - It is commonly used in combination with tenofovir (as in Truvada) for enhanced efficacy in HIV/HBV coinfection. - **Tenofovir remains the best answer** due to its superior resistance profile and status as first-line HBV therapy. *Nevirapine* - **Nevirapine** is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used specifically for **HIV infection**. - It does not demonstrate antiviral activity against **Hepatitis B virus (HBV)** or other forms of viral hepatitis.

Question 1

A woman presenting with symptoms of urinary tract infection was prescribed a drug that    causes tendon rupture and arthropathy. What is the mechanism of action of the drug?

Accepted Answer

DNA gyrase inhibition

Answer

Ribosomal inhibition

Answer

Cell wall synthesis

Answer

Inhibition of folic acid synthesis

Question 2

Drug of choice for invasive aspergillosis is

Accepted Answer

Voriconazole

Answer

Posaconazole

Answer

Liposomal AMB

Answer

Caspofungin

Question 3

What is the primary site of action of amphotericin B?

Accepted Answer

Plasma membrane

Answer

Cell wall

Answer

Protein

Answer

Ribosomes

Question 4

What is the most appropriate antibiotic choice for a bedridden patient with catheter-related urinary tract infection (UTI) and pneumonia?

Accepted Answer

Piperacillin-tazobactam

Answer

Amoxicillin

Answer

3rd gen cephalosporins

Answer

2nd gen cephalosporins

Question 5

What is the drug of choice for treating Cyclosporiasis?

Accepted Answer

Trimethoprim-sulfamethoxazole combination

Answer

Paromomycin

Answer

Metronidazole

Answer

Cyclosporin

Question 6

Burkholderia cepacia is resistant to which of the following antibiotics?

Accepted Answer

Cefotetan

Answer

Trimethoprim-sulfamethoxazole

Answer

Ceftazidime

Answer

Temocillin

Question 7

What is the drug of choice for treating isosporiasis?

Accepted Answer

Co-trimoxazole

Answer

Penicillin G

Answer

Benzathine penicillin

Answer

Albendazole

Question 8

Mycoplasma is inherently resistant to which of the following antibiotic classes due to its lack of a peptidoglycan cell wall?

Accepted Answer

Ceftriaxone (a cephalosporin)

Answer

Penicillins (e.g., Amoxicillin)

Answer

Aminoglycosides (e.g., Gentamicin)

Answer

Fluoroquinolones (e.g., Ciprofloxacin)

Question 9

Mechanism of action of Oseltamivir?

Accepted Answer

Neuraminidase inhibitor

Answer

Inhibitor of protein synthesis

Answer

Inhibitor of thymidylate synthetase

Answer

Pyrimidine analogs

Question 10

Which antiretroviral drug also has anti-hepatitis activity?

Accepted Answer

Tenofovir

Answer

Abacavir

Answer

Nevirapine

Answer

Emtricitabine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?